Exact Mass: 394.0154898
Exact Mass Matches: 394.0154898
Found 111 metabolites which its exact mass value is equals to given mass value 394.0154898,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isorhamnetin 3-sulfate
C16H10O10S (393.99946800000004)
Alilusem
C17H15ClN2O5S (394.03901700000006)
Kaempferol 7,4-dimethyl ether 3-O-sulfate
C17H14O9S (394.03585140000007)
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
C15H24Br2O2 (394.01429239999993)
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
1h,1h,2h,3h,3h-perfluorononane-1,2-diol
C9H7F13O2 (394.02384379999995)
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
C20H14N2O5S (394.06233940000004)
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
2-BUTYNYLTRIPHENYLPHOSPHONIUM BROMIDE
C22H20BrP (394.04859100000004)
diphenyliodonium trifluoroacetate
C14H10F3IO2 (393.96776259999996)
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
Alilusem
C17H15ClN2O5S (394.03901700000006)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
C16H10O10S-2 (393.99946800000004)
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
C16H15BrN2O3S (393.99867000000006)
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
C20H14N2O5S (394.06233940000004)
Uracil octosyl acid 5-phosphate
C12H15N2O11P (394.04134500000004)
An N-glycosyl compound with formula C12H15N2O11P that is a common intermediate in the biosynthesis of nikkomycins and polyoxins by bacteria.
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
C16H14N2O4S3 (394.01156840000004)
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
C17H15ClN2O5S (394.03901700000006)
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
C17H15ClN2O3S2 (394.02125900000004)
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2,3-dideoxy-alpha-D-ribofuranos-5-yl group.
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
C22H16Cl2N2O (394.06396259999997)
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
C16H10O10S (393.99946800000004)
3-(enolpyruvyl)uridine 5-monophosphate
C12H15N2O11P (394.04134500000004)
A uridine 5-phosphate that is UMP in which the hydroxy hydrogen at position 3 has been replaced by an enolpyruvyl group.
M1002
C15H8F6N2O2S (394.02106599999996)
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(5s)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
5-(10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl)oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(2e,4e,7s)-8,8,8-trichloro-7-methyl-n-[(1r)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(5r)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
C15H24Br2O2 (394.01429239999993)
2-(3-chloro-2,5-dihydroxyphenyl)-5-hydroxy-3,7,8-trimethoxychromen-4-one
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
(5r)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(5s)-5-[(1e,3r)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
methyl 5-bromo-10-hydroxy-8-methyl-3,11-dioxo-1h-oxepino[4,3-b]chromene-1-carboxylate
4-[2-(5-bromo-2-oxo-1h-indol-3-ylidene)hydrazin-1-yl]benzenesulfonamide
C14H11BrN4O3S (393.97351960000003)
2-[3-chloro-2-hydroxy-4-methoxy-6-(methoxycarbonyl)benzoyl]-6-hydroxy-4-methylbenzoic acid
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
C17H14O9S (394.03585140000007)
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(5s)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(2e,4e)-8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5r)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(5r,6r)-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5s)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
5-(10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl)oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
C15H24Br2O2 (394.01429239999993)